Effets ergogéniques des β2 agonistes : mode d'action et enjeux pour la lutte antidopage (notice n° 1009418)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02562cam a2200349 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250125140259.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Fur, Marie Amélie Le |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Effets ergogéniques des β2 agonistes : mode d'action et enjeux pour la lutte antidopage |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2012.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 79 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Les β2 agonistes constituent une classe de molécules pharmacologiques utilisées classiquement dans le traitement de l’asthme et d’autres maladies respiratoires. Depuis 1991, l’AMA (agence mondiale anti-dopage) oriente notamment sa lutte vis à vis de l’usage illicite des β2 agonistes. En effet, il semblerait que ces molécules soient couramment utilisées par les sportifs en raison de leur pouvoir ergogénique et de leurs fonctions anabolisantes et lipolitiques. Cet article a pour objectif de regrouper les différentes données expérimentales relevant les effets de ces molécules sur les performances aérobie et anaérobie ainsi que de disséquer les mécanismes de signalisation cellulaires induits par ces substances.Reçu le 23 Novembre 2011 – Accepté le 23 Janvier 2012 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Ergogenic effects of β2 agonistsβ2 adrenergic agonists are a class of drugs usually used in the treatment of asthma and other pulmonary diseases. Since 1991, increasing concern has been expressed over the widespread use of β2 agonists among elite athletes. Indeed, it would seem that these molecules are usually used in elite competitive athletes fearing potential ergogenic doping effects and their improvement of ventilatory and muscular functions. The aim of this article is to gather the experimental data raising the effects of these molecules on aerobic and anaerobic performances, and also detail the physiological mechanisms borrowed by these substances. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | athlètes de haut niveau |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | performance aérobie |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | β2 agonistes |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | performance anaérobie |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | effet |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | dopage |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | ergogénique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | aerobic performance |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | β2 agonists |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | ergogenic effects |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | anaerobic performance |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | elite competitive athletes |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | doping |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sanchez, Anthony M.J. |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Candau, Robin |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Movement & Sport Sciences - Science & Motricité | 77 | 3 | 2012-07-11 | p. 29-37 | 2118-5735 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-movement-and-sport-sciences-2012-3-page-29?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-movement-and-sport-sciences-2012-3-page-29?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux